Tauopathies Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tauopathies Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 SEL-141
1.2.3 RDC-5
1.2.4 YM-08
1.2.5 Thiamet-G
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tauopathies Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tauopathies Treatment Market Perspective (2017-2028)
2.2 Tauopathies Treatment Growth Trends by Region
2.2.1 Tauopathies Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tauopathies Treatment Historic Market Size by Region (2017-2022)
2.2.3 Tauopathies Treatment Forecasted Market Size by Region (2023-2028)
2.3 Tauopathies Treatment Market Dynamics
2.3.1 Tauopathies Treatment Industry Trends
2.3.2 Tauopathies Treatment Market Drivers
2.3.3 Tauopathies Treatment Market Challenges
2.3.4 Tauopathies Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tauopathies Treatment Players by Revenue
3.1.1 Global Top Tauopathies Treatment Players by Revenue (2017-2022)
3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Tauopathies Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tauopathies Treatment Revenue
3.4 Global Tauopathies Treatment Market Concentration Ratio
3.4.1 Global Tauopathies Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tauopathies Treatment Revenue in 2021
3.5 Tauopathies Treatment Key Players Head office and Area Served
3.6 Key Players Tauopathies Treatment Product Solution and Service
3.7 Date of Enter into Tauopathies Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tauopathies Treatment Breakdown Data by Type
4.1 Global Tauopathies Treatment Historic Market Size by Type (2017-2022)
4.2 Global Tauopathies Treatment Forecasted Market Size by Type (2023-2028)
5 Tauopathies Treatment Breakdown Data by Application
5.1 Global Tauopathies Treatment Historic Market Size by Application (2017-2022)
5.2 Global Tauopathies Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tauopathies Treatment Market Size (2017-2028)
6.2 North America Tauopathies Treatment Market Size by Type
6.2.1 North America Tauopathies Treatment Market Size by Type (2017-2022)
6.2.2 North America Tauopathies Treatment Market Size by Type (2023-2028)
6.2.3 North America Tauopathies Treatment Market Share by Type (2017-2028)
6.3 North America Tauopathies Treatment Market Size by Application
6.3.1 North America Tauopathies Treatment Market Size by Application (2017-2022)
6.3.2 North America Tauopathies Treatment Market Size by Application (2023-2028)
6.3.3 North America Tauopathies Treatment Market Share by Application (2017-2028)
6.4 North America Tauopathies Treatment Market Size by Country
6.4.1 North America Tauopathies Treatment Market Size by Country (2017-2022)
6.4.2 North America Tauopathies Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tauopathies Treatment Market Size (2017-2028)
7.2 Europe Tauopathies Treatment Market Size by Type
7.2.1 Europe Tauopathies Treatment Market Size by Type (2017-2022)
7.2.2 Europe Tauopathies Treatment Market Size by Type (2023-2028)
7.2.3 Europe Tauopathies Treatment Market Share by Type (2017-2028)
7.3 Europe Tauopathies Treatment Market Size by Application
7.3.1 Europe Tauopathies Treatment Market Size by Application (2017-2022)
7.3.2 Europe Tauopathies Treatment Market Size by Application (2023-2028)
7.3.3 Europe Tauopathies Treatment Market Share by Application (2017-2028)
7.4 Europe Tauopathies Treatment Market Size by Country
7.4.1 Europe Tauopathies Treatment Market Size by Country (2017-2022)
7.4.2 Europe Tauopathies Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tauopathies Treatment Market Size (2017-2028)
8.2 Asia-Pacific Tauopathies Treatment Market Size by Type
8.2.1 Asia-Pacific Tauopathies Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tauopathies Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tauopathies Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Tauopathies Treatment Market Size by Application
8.3.1 Asia-Pacific Tauopathies Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tauopathies Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tauopathies Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Tauopathies Treatment Market Size by Region
8.4.1 Asia-Pacific Tauopathies Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tauopathies Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tauopathies Treatment Market Size (2017-2028)
9.2 Latin America Tauopathies Treatment Market Size by Type
9.2.1 Latin America Tauopathies Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Tauopathies Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Tauopathies Treatment Market Share by Type (2017-2028)
9.3 Latin America Tauopathies Treatment Market Size by Application
9.3.1 Latin America Tauopathies Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Tauopathies Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Tauopathies Treatment Market Share by Application (2017-2028)
9.4 Latin America Tauopathies Treatment Market Size by Country
9.4.1 Latin America Tauopathies Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Tauopathies Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tauopathies Treatment Market Size (2017-2028)
10.2 Middle East & Africa Tauopathies Treatment Market Size by Type
10.2.1 Middle East & Africa Tauopathies Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tauopathies Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tauopathies Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Tauopathies Treatment Market Size by Application
10.3.1 Middle East & Africa Tauopathies Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tauopathies Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tauopathies Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Tauopathies Treatment Market Size by Country
10.4.1 Middle East & Africa Tauopathies Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tauopathies Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2017-2022)
11.1.5 Bristol-Myers Squibb Company Recent Developments
11.2 Selvita S.A
11.2.1 Selvita S.A Company Details
11.2.2 Selvita S.A Business Overview
11.2.3 Selvita S.A Tauopathies Treatment Introduction
11.2.4 Selvita S.A Revenue in Tauopathies Treatment Business (2017-2022)
11.2.5 Selvita S.A Recent Developments
11.3 SK Biopharmaceuticals Co., Ltd.
11.3.1 SK Biopharmaceuticals Co., Ltd. Company Details
11.3.2 SK Biopharmaceuticals Co., Ltd. Business Overview
11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Introduction
11.3.4 SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2017-2022)
11.3.5 SK Biopharmaceuticals Co., Ltd. Recent Developments
11.4 Chronos Therapeutics Limited
11.4.1 Chronos Therapeutics Limited Company Details
11.4.2 Chronos Therapeutics Limited Business Overview
11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Introduction
11.4.4 Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2017-2022)
11.4.5 Chronos Therapeutics Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tauopathies Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of SEL-141
Table 3. Key Players of RDC-5
Table 4. Key Players of YM-08
Table 5. Key Players of Thiamet-G
Table 6. Key Players of Others
Table 7. Global Tauopathies Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Tauopathies Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Tauopathies Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Tauopathies Treatment Market Share by Region (2017-2022)
Table 11. Global Tauopathies Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Tauopathies Treatment Market Share by Region (2023-2028)
Table 13. Tauopathies Treatment Market Trends
Table 14. Tauopathies Treatment Market Drivers
Table 15. Tauopathies Treatment Market Challenges
Table 16. Tauopathies Treatment Market Restraints
Table 17. Global Tauopathies Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Tauopathies Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Tauopathies Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tauopathies Treatment as of 2021)
Table 20. Ranking of Global Top Tauopathies Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Tauopathies Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tauopathies Treatment Product Solution and Service
Table 24. Date of Enter into Tauopathies Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Tauopathies Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Tauopathies Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Tauopathies Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Tauopathies Treatment Revenue Share by Application (2017-2022)
Table 32. Global Tauopathies Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Tauopathies Treatment Revenue Share by Application (2023-2028)
Table 34. North America Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Tauopathies Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Tauopathies Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Tauopathies Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Tauopathies Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Tauopathies Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Tauopathies Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Tauopathies Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Tauopathies Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Tauopathies Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Tauopathies Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Tauopathies Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Tauopathies Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Tauopathies Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Tauopathies Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Tauopathies Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Tauopathies Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Tauopathies Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Tauopathies Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Tauopathies Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Tauopathies Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Tauopathies Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Tauopathies Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Company Details
Table 65. Bristol-Myers Squibb Company Business Overview
Table 66. Bristol-Myers Squibb Company Tauopathies Treatment Product
Table 67. Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2017-2022) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Recent Developments
Table 69. Selvita S.A Company Details
Table 70. Selvita S.A Business Overview
Table 71. Selvita S.A Tauopathies Treatment Product
Table 72. Selvita S.A Revenue in Tauopathies Treatment Business (2017-2022) & (US$ Million)
Table 73. Selvita S.A Recent Developments
Table 74. SK Biopharmaceuticals Co., Ltd. Company Details
Table 75. SK Biopharmaceuticals Co., Ltd. Business Overview
Table 76. SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Product
Table 77. SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2017-2022) & (US$ Million)
Table 78. SK Biopharmaceuticals Co., Ltd. Recent Developments
Table 79. Chronos Therapeutics Limited Company Details
Table 80. Chronos Therapeutics Limited Business Overview
Table 81. Chronos Therapeutics Limited Tauopathies Treatment Product
Table 82. Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2017-2022) & (US$ Million)
Table 83. Chronos Therapeutics Limited Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tauopathies Treatment Market Share by Type: 2021 VS 2028
Figure 2. SEL-141 Features
Figure 3. RDC-5 Features
Figure 4. YM-08 Features
Figure 5. Thiamet-G Features
Figure 6. Others Features
Figure 7. Global Tauopathies Treatment Market Share by Application: 2021 VS 2028
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Tauopathies Treatment Report Years Considered
Figure 12. Global Tauopathies Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Tauopathies Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Tauopathies Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Tauopathies Treatment Market Share by Players in 2021
Figure 16. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tauopathies Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Tauopathies Treatment Revenue in 2021
Figure 18. North America Tauopathies Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Tauopathies Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Tauopathies Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Tauopathies Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Tauopathies Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Tauopathies Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Tauopathies Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Tauopathies Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Tauopathies Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Tauopathies Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Tauopathies Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Tauopathies Treatment Market Size Share by Region (2017-2028)
Figure 38. China Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Tauopathies Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Tauopathies Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Tauopathies Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Tauopathies Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Tauopathies Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Tauopathies Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Tauopathies Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Tauopathies Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Tauopathies Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Tauopathies Treatment Business (2017-2022)
Figure 58. Selvita S.A Revenue Growth Rate in Tauopathies Treatment Business (2017-2022)
Figure 59. SK Biopharmaceuticals Co., Ltd. Revenue Growth Rate in Tauopathies Treatment Business (2017-2022)
Figure 60. Chronos Therapeutics Limited Revenue Growth Rate in Tauopathies Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
